Proprietary AI analyst is now available
- Public Comps
- Cannara Biotech
Cannara Biotech Valuation Multiples
Discover Cannara Biotech's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Grown Rogue International, Ispire Technology, Ascend Wellness Holdings, Jushi Holdings and more.
Cannara Biotech Overview
About Cannara Biotech
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
Founded
2017
HQ

Employees
452
Website
Financials (LTM)
EV
$122M
Valuation Multiples
Start free trialCannara Biotech Financials
Cannara Biotech reported last 12-month revenue of $85M and EBITDA of $22M.
In the same LTM period, Cannara Biotech generated $40M in gross profit, $22M in EBITDA, and $9M in net income.
Revenue (LTM)
Cannara Biotech P&L
In the most recent fiscal year, Cannara Biotech reported revenue of $76M and EBITDA of $20M.
Cannara Biotech is profitable as of last fiscal year, with gross margin of 44%, EBITDA margin of 27%, and net margin of 12%.
Financial data powered by Morningstar, Inc.
Cannara Biotech Stock Performance
Cannara Biotech has current market cap of $113M, and enterprise value of $122M.
Market Cap Evolution
Cannara Biotech's stock price is $1.14.
Cannara Biotech share price decreased by 5.6% in the last 30 days.
Cannara Biotech has an EPS (earnings per share) of $0.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $122M | $113M | -1.9% | -5.6% | - | - | $0.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCannara Biotech Valuation Multiples
Cannara Biotech trades at 1.4x EV/Revenue multiple, and 5.5x EV/EBITDA.
EV / Revenue (LTM)
Cannara Biotech Financial Valuation Multiples
As of June 23, 2026, Cannara Biotech has market cap of $113M and EV of $122M.
Cannara Biotech has a P/E ratio of 12.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cannara Biotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cannara Biotech Margins & Growth Rates
Cannara Biotech grew revenue by 15% and EBITDA by 11% in the last fiscal year.
In the most recent fiscal year, Cannara Biotech reported gross margin of 44%, EBITDA margin of 27%, and net margin of 12%.
Cannara Biotech Margins
Cannara Biotech Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cannara Biotech Operational KPIs
Cannara Biotech's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Cannara Biotech's Rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cannara Biotech's Rule of X is 62% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Cannara Biotech Competitors
Cannara Biotech competitors include Grown Rogue International, Ispire Technology, Ascend Wellness Holdings, Jushi Holdings, Organigram Global, Aurora Cannabis, WM Tech, Planet 13, TerrAscend and MariMed.
Most Cannara Biotech public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.8x | - | 13.6x | - | |||
| 0.7x | 1.0x | (2.9x) | (2218.4x) | |||
| 1.3x | 1.4x | 5.7x | 5.9x | |||
| 1.3x | 1.3x | 7.1x | 7.1x | |||
| 0.7x | 0.6x | 10.3x | 8.9x | |||
| 0.5x | 0.5x | 3.0x | 3.4x | |||
| 0.1x | 0.1x | 0.3x | 0.4x | |||
| 0.9x | 0.9x | (9.1x) | (14.6x) | |||
This data is available for Pro users. Sign up to see all Cannara Biotech competitors and their valuation data. Start Free Trial | ||||||
Cannara Biotech VC Funding History
Before going public, Cannara Biotech raised $18M in total equity funding, across 1 round.
Cannara Biotech Funding Rounds
Acquisitions by Cannara Biotech
Cannara Biotech has acquired 2 companies to date.
Last acquisition by Cannara Biotech was on May 5th 2026. Cannara Biotech acquired Medican Organic for $2M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Cannara Biotech
| Description | Medican Organic is a retail company that sells cannabis-related products. | shopCBD.com is a U.S. online retailer specializing in hemp-derived CBD products including oils, gummies, and topicals from brands like Charlotte's Web. Operating from Denver, it ships nationwide with lab-tested items compliant with 2018 Farm Bill standards. |
| HQ Country | ||
| HQ City | Quebec City | Los Angeles, CA |
| Deal Date | 5 May 2026 | 26 May 2020 |
| Valuation | $2M | $10M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Cannara Biotech acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cannara Biotech
| When was Cannara Biotech founded? | Cannara Biotech was founded in 2017. |
| Where is Cannara Biotech headquartered? | Cannara Biotech is headquartered in Canada. |
| How many employees does Cannara Biotech have? | As of today, Cannara Biotech has over 452 employees. |
| Is Cannara Biotech publicly listed? | Yes, Cannara Biotech is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Cannara Biotech? | Cannara Biotech trades under LOVE ticker. |
| When did Cannara Biotech go public? | Cannara Biotech went public in 2019. |
| Who are competitors of Cannara Biotech? | Cannara Biotech main competitors include Grown Rogue International, Ispire Technology, Ascend Wellness Holdings, Jushi Holdings, Organigram Global, Aurora Cannabis, WM Tech, Planet 13, TerrAscend, MariMed. |
| What is the current market cap of Cannara Biotech? | Cannara Biotech's current market cap is $113M. |
| What is the current revenue of Cannara Biotech? | Cannara Biotech's last 12 months revenue is $85M. |
| What is the current revenue growth of Cannara Biotech? | Cannara Biotech revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Cannara Biotech? | Current revenue multiple of Cannara Biotech is 1.4x. |
| What is the current EBITDA of Cannara Biotech? | Cannara Biotech's last 12 months EBITDA is $22M. |
| What is Cannara Biotech's EBITDA margin? | Cannara Biotech's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Cannara Biotech? | Current EBITDA multiple of Cannara Biotech is 5.5x. |
| What is the current FCF of Cannara Biotech? | Cannara Biotech's last 12 months FCF is $9M. |
| What is Cannara Biotech's FCF margin? | Cannara Biotech's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Cannara Biotech? | Current FCF multiple of Cannara Biotech is 13.9x. |
| How many companies Cannara Biotech has acquired to date? | As of June 2026, Cannara Biotech has acquired 2 companies. |
| What was the largest acquisition by Cannara Biotech? | $10M acquisition of shopCBD.com on 26th May 2020 was the largest M&A Cannara Biotech has done to date. |
| What companies Cannara Biotech acquired? | Cannara Biotech acquired shopCBD.com and Medican Organic. |
| In how many companies Cannara Biotech has invested to date? | Cannara Biotech hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Cannara Biotech
Lists including Cannara Biotech
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

